APRE vs GILD: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Gilead Sciences Inc in 2026
APRE
Aprea Therapeutics Inc
$0.88
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | APRE | GILD | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | -1619.1% | 78.7% | GILD |
Analyze APRE
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or GILD a better investment?
Comparing APRE and GILD: Aprea Therapeutics Inc has a market cap of $6.22M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and GILD?
APRE (Aprea Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for APRE.
Which company is more profitable: APRE or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to -1619.1% for APRE.
Which is the larger company: APRE or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $6.22M for APRE.
Should I buy APRE or GILD in 2026?
Both APRE and GILD have investment merit. APRE trades at $0.88 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and GILD stock?
Key differences: Market Cap ($6.22M vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-1619.1% vs 78.7%).